Dr. Wangjam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
161 Fort Washington Ave
The Herbert Irving Comprehensive Cancer Center
New York, NY 10032Phone+1 212-342-0530
Summary
- Dr. Tamna Wangjam is a hematologist- oncologist in New York, NY and is affiliated with The Herbert Irving Comprehensive Cancer Center, with New York-Presbyterian / Columbia University Irving Medical Center. She received her medical degree from University of Delhi- Lady Hardinge Medical College and has been in practice 8 years. She specializes in care and treatment of patients with hematologic malignancies and other diseases, with immunotherapy, chemotherapy, stem cell transplantation and cellular therapy.
Education & Training
- Stanford University School of MedicineFellowship, Blood and Marrow Transplant- Cellular Therapy, 2017 - 2018
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2014 - 2017
- Sinai Hospital of BaltimoreResidency, Internal Medicine, 2012 - 2014
- Sinai Hospital of BaltimoreInternship, Internal Medicine, 2011 - 2012
- Lady Hardinge Medical CollegeClass of 2009
Certifications & Licensure
- CA State Medical License 2017 - 2025
- NY State Medical License 2023 - 2025
- LA State Medical License 2019 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Successfully treated acute adult T-cell leukemia with haploidentical stem cell transplantation.Aswani Thurlapati, Christopher Graham, Kyle Boudreaux, Tamna Wangjam
Proceedings. 2022-01-01 - 13 citationsTitle: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell...Surbhi Sidana, Shaji Kumar, Raphael Fraser, Noel Estrada-Merly, Sergio Giralt
Transplantation and Cellular Therapy. 2021-11-12 - 19 citationsMissed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy studyAshrit Multani, Libby S. Allard, Tamna Wangjam, R. Alejandro Sica, David J Epstein
Blood Advances. 2019-11-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: